Avanir Pharmaceuticals Announces Date of Fiscal 2014 First Quarter Financial Results and Conference Call
January 28 2014 - 8:30AM
Avanir Pharmaceuticals, Inc. (Nasdaq:AVNR) will
report financial results for the quarter ended December 31, 2013
after market close on Wednesday February 5, 2014. The company will
conduct a conference call and an audio webcast at 1:30 pm Pacific
Time (4:30 pm Eastern Time) on the same day.
Conference Call Information: Domestic callers: 1 (866) 318-8611
International callers: +1 (617) 399-5130 Passcode: 19078797
Webcast information: Visit http://www.avanir.com.
A webcast replay will be available on the Avanir Web site for 30
days. A telephone replay will be available for 48 hours following
the conclusion of the call by dialing 1 (888) 286-8010 for domestic
callers, or +1 (617) 801-6888 for international callers, and
entering reservation code 10946464.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company
focused on bringing innovative medicines to patients with central
nervous system disorders of high unmet medical need. As part of our
commitment, we have extensively invested in our pipeline and are
dedicated to advancing medicines that can substantially improve the
lives of patients and their loved ones. For more information about
Avanir, please visit www.avanir.com.
AVANIR® is a registered trademark owned by Avanir
Pharmaceuticals, Inc.
©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.
CONTACT: Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700